DRUG SURVIVAL AND PREDICTOR FACTORS OF DISCONTINUATION IN AXIAL SPONDYLOARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB AND SECUKINUMAB

ATALAR E., KONAK H. E., AKYÜZ DAĞLI P., ÖZDEMİR ULUSOY B., KARAKAŞ Ö., ORHAN K., ...Daha Fazla

EULAR European Congress of Rheumatology 2024, Avusturya, 12 - 15 Haziran 2024, cilt.83, (Özet Bildiri)